Supernus Pharmaceuticals’ Onapgo provides a continuous infusion of apomorphine to manage “off” periods experienced by Parkinson’s disease patients. Approval of Onapgo comes after the FDA twice turned back applications for the drug/device combination product.
A study found propranolol significantly lowers ischemic stroke risk in women with migraine, highlighting its potential for stroke prevention in high-risk groups.
In order to make full use of available LA rental properties, Gov. Gavin Newsom issued an executive order to change some rent rules.
Suicide claimed more than 49,000 lives in the United States in 2022, the highest number ever recorded. Research shows that health care providers can play…
You may have heard of microplastics, but what are nanoplastics and should you be concerned about them? A researcher explains what the science shows and…
Doctors for America, a nonprofit membership organization, filed the case Tuesday in Washington federal court.
Traveling at 45,000 mph shouldn’t be possible on Earth. A TOP CAPITOL HILL in July 2023, lawmakers sat before witnesses, experts, and members of the…
Click on the article title to read more.
Streetleaf’s solar streetlights can withstand Category 5 hurricanes, and it aims to deploy them across Florida to boost storm resilience.
This week in health care politics and policy: RFK Jr. faces a key test, and Dr. Oz’s rise to a top Trump role.
Brightpick, a maker of autonomous mobile robots, on Tuesday announced a lofty addition to its current line. The appropriately named Giraffe system is
